- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.03. | Earnings call: AirSculpt Technologies posts robust Q4 growth | 1 | Investing.com | ||
| 27.02. | Airsculpt Technologies, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 27.02. | AirSculpt Technologies GAAP EPS of -$0.08 misses by $0.10, revenue of $47.6M misses by $0.23M | 1 | Seeking Alpha | ||
| 27.02. | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports Double Digit Revenue Growth for the Fourth Quarter and Full Year 2023 | 231 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 27.02. | Airsculpt Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.02. | Fat-Reduction Focused AirSculpt Hit With Short Report: Unethical Marketing Practices, Troubling Safety Concerns, Credibility Issues | 1 | Benzinga.com | ||
| 23.02. | AirSculpt slides after Fuzzy Panda takes short position | 1 | Reuters | ||
| 23.02. | Airsculpt shares slide after Fuzzy Panda takes short position | 1 | Reuters | ||
| 31.01. | Airsculpt Technologies, Inc.: AirSculpt Technologies Announces Fourth Quarter 2023 Earnings Release Date and Conference Call | 1 | GlobeNewswire (USA) | ||
| 16.11.23 | Morgan Stanley Maintains Equal-Weight Rating for AirSculpt Technologies: Here's What You Need To Know | 2 | Benzinga.com | ||
| 13.11.23 | Airsculpt Technologies, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 10.11.23 | AirSculpt Technologies Non-GAAP EPS of $0.05, revenue of $46.8M | 1 | Seeking Alpha | ||
| 09.11.23 | Airsculpt Technologies, Inc.: AirSculpt Technologies Announces Third Quarter 2023 Results and Reaffirms 2023 Guidance | 218 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 09.11.23 | Airsculpt Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.11.23 | Earnings Preview For AirSculpt Technologies | 1 | Benzinga.com | ||
| 08.11.23 | AirSculpt (AIRS) to Report Q3 Earnings: What's in the Cards? | 1 | Zacks | ||
| 27.10.23 | Airsculpt Technologies, Inc.: AirSculpt Technologies Announces Third Quarter 2023 Earnings Release Date and Conference Call | 1 | GlobeNewswire (USA) | ||
| 05.10.23 | Airsculpt Technologies, Inc.: AirSculpt Technologies Announces Strong Preliminary Third Quarter 2023 Revenue Results and Updates 2023 Revenue and Adjusted EBITDA Guidance | 228 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 11.08.23 | Airsculpt Technologies, Inc.: AirSculpt Technologies Announces Second Quarter 2023 Results and Reaffirms 2023 Guidance | 402 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Aug. 11, 2023 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 11.07.23 | Airsculpt Technologies, Inc.: AirSculpt Technologies Announces Strong Preliminary Second Quarter 2023 Revenue, Reaffirms 2023 Revenue Guidance and Updates 2023 Adjusted EBITDA Guidance | 189 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., July 11, 2023 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 11,970 | -3,12 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| NANO-X IMAGING | 9,070 | 0,00 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
| BUTTERFLY NETWORK | 0,822 | 0,00 % | Butterfly Network expands maternal ultrasound efforts across Africa | ||
| GOODRX | 6,740 | +3,69 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 11,915 | -0,87 % | The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results | ||
| CARMAT | 3,830 | +1,06 % | CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024 | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| HYPERFINE | 0,810 | -10,99 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROGYNY | 31,880 | -2,66 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
| MIMEDX | 6,160 | -2,69 % | MiMedx Group, Inc: MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30 | ||
| BIOMERICA | 0,751 | 0,00 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
| ATRICURE | 23,390 | -0,26 % | AtriCure launches new cryoablation probe | ||
| ATRION | 372,00 | -3,12 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 19,200 | +1,91 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen | |
| AMWELL | 0,521 | 0,00 % | Amwell® to Report First Quarter 2024 Operating Results May 1 | ||
| OUTSET MEDICAL | 2,240 | +3,70 % | Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis |
AIRSCULPT TECHNOLOGIES INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 5,440 Euro und damit +0,55 % im Plus. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
